Center for Psykisk Sundhedsfremme CFPS - Implementeringsenhed ApS

 

Quicksearch
from your own companies




Analyst: XBRLDenmark
 
Loading...

Loading...

Loading...

Loading...

 
Loading...

Bankruptcy Risk 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Bankruptcy risk for industry  0.6% 0.6% 0.6% 0.6% 0.6%  
Bankruptcy risk  4.0% 4.3% 13.4% 20.2% 7.9%  
Credit score (0-100)  51 48 16 5 30  
Credit rating  BBB BBB BB B BB  
Credit limit (kDKK)  0.0 0.0 0.0 0.0 0.0  

How are these values calculated?
 
View the automatically generated explanation of bankruptcy risk

Income statement (kDKK) 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12

Net sales  0 0 0 0 0  
Gross profit  2,221 4,065 -8.6 -70.9 64.7  
EBITDA  1.3 1,746 -569 -247 63.8  
EBIT  -7.2 1,731 -569 -247 63.8  
Pre-tax profit (PTP)  -9.4 1,725.0 -545.3 -230.6 52.4  
Net earnings  -10.8 1,343.9 -560.0 -230.6 52.4  
Pre-tax profit without non-rec. items  -9.4 1,725 -545 -231 52.4  

 
See the entire income statement

Balance sheet (kDKK) 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12

Tangible assets total  14.2 0.0 0.0 0.0 0.0  
Shareholders equity total  528 1,872 912 681 734  
Interest-bearing liabilities  4.5 2.4 0.0 0.0 0.0  
Balance sheet total (assets)  2,422 3,012 1,299 1,043 796  

Net Debt  -1,174 -1,307 -59.0 -37.0 -58.2  
 
See the entire balance sheet

Volume 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12

Net sales  0 0 0 0 0  
Net sales growth  0.0% 0.0% 0.0% 0.0% 0.0%  
Gross profit  2,221 4,065 -8.6 -70.9 64.7  
Gross profit growth  196.9% 83.0% 0.0% -720.2% 0.0%  
Employees  2 2 2 1 1  
Employee growth %  100.0% 0.0% 0.0% -50.0% 0.0%  
Employee expenses  0.0 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  2,422 3,012 1,299 1,043 796  
Balance sheet change%  -41.8% 24.4% -56.9% -19.7% -23.7%  
Added value  1.3 1,746.1 -569.2 -247.0 63.8  
Added value %  0.0% 0.0% 0.0% 0.0% 0.0%  
Investments  -17 -29 0 0 0  

Net sales trend  0.0 0.0 0.0 0.0 0.0  
EBIT trend  -3.0 1.0 -1.0 -2.0 1.0  

Profitability 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
EBITDA %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT to gross profit (%)  -0.3% 42.6% 6,581.4% 348.2% 98.6%  
Net Earnings %  0.0% 0.0% 0.0% 0.0% 0.0%  
Profit before depreciation and extraordinary items %  0.0% 0.0% 0.0% 0.0% 0.0%  
Pre tax profit less extraordinaries %  0.0% 0.0% 0.0% 0.0% 0.0%  
ROA %  -0.2% 63.7% -25.0% -19.2% 8.7%  
ROI %  -1.3% 143.9% -38.7% -28.3% 11.3%  
ROE %  -2.0% 112.0% -40.2% -29.0% 7.4%  

Solidity 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Equity ratio %  57.2% 62.1% 70.2% 65.3% 92.2%  
Relative indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Relative net indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net int. bear. debt to EBITDA, %  -91,319.4% -74.9% 10.4% 15.0% -91.2%  
Gearing %  0.9% 0.1% 0.0% 0.0% 0.0%  
Net interest  0 0 0 0 0  
Financing costs %  13.2% 181.4% 493.4% 0.0% 0.0%  

Liquidity 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Quick Ratio  5.7 2.6 3.4 2.9 12.7  
Current Ratio  1.3 2.6 3.4 2.9 12.7  
Cash and cash equivalent  1,178.9 1,309.4 59.0 37.0 58.2  

Capital use efficiency 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Trade debtors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Trade creditors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Current assets / Net sales %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net working capital  513.7 1,871.8 911.9 681.3 733.6  
Net working capital %  0.0% 0.0% 0.0% 0.0% 0.0%  

Employee efficiency 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Net sales / employee  0 0 0 0 0  
Added value / employee  1 873 -285 -247 64  
Employee expenses / employee  0 0 0 0 0  
EBITDA / employee  1 873 -285 -247 64  
EBIT / employee  -4 866 -285 -247 64  
Net earnings / employee  -5 672 -280 -231 52